Opinions

While increasing evidence from studies support pregnancy after cancer treatment, data gaps persist, particularly regarding the impact of novel therapies on fertility 

Recent findings regarding the role of tumour promoters in cancer development should lead to a review of the mechanisms of action of existing environmental carcinogens

Identifying the trigger that switches neutrophils from protumour to antitumour activity in the tumour microenvironment could open the door to new therapeutic options

Technology promises to improve understanding of cancer risk and lesion biology, but clear regulation is urged to implement innovation in cancer screening programmes  

The key to overcoming barriers to effective prevention and treatment in resource-restricted settings involves cooperation between multiple organisations, including medical societies, patient groups, pharmaceutical companies and regulatory agencies 

Facilitating an open dialogue with patients, to better understand their needs, makes research efforts more valuable in the long-term 

However, there are still many obstacles faced by investigators in achieving effective patient involvement in research

Among all the stakeholders involved, oncology societies can play a pivotal role to facilitate efficient clinical investigations  

As science and innovations continue to progress in gynaecological oncology, there is a need to rethink our perceptions to ensure clinical management and research advance accordingly

Conflicting clinical results on the benefits of combined radiotherapy and immunotherapy may derive from differences in treatment sequencing